A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes

NCT01044017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Placebo
DRUG: RO4998452

Sponsor

Hoffmann-La Roche